Yong Yu

Insider Reports History

Location
Westlake Village, CA
Signature
/s/ Thomas Zindrick, J.D. Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Yong Yu:

Company Role Class Num Shares Value Price $ Report Date Ownership
GENELUX Corp SVP, Clinical Development Common Stock 145,844 $783,094 $5.37 17 Nov 2025 Direct
GENELUX Corp SVP, Clinical Development Stock Option (Right to Buy) 65,000 01 Sep 2025 Direct

Insider Reports Filed by Yong Yu

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GNLX GENELUX Corp 01 Sep 2025 4 $0 4 SVP, Clinical Development 03 Sep 2025, 16:15
GNLX GENELUX Corp 27 Aug 2025 2 $0 4 SVP, Clinical Development 29 Aug 2025, 16:30
GNLX GENELUX Corp 21 Aug 2025 2 -$16,032 4 SVP, Clinical Development 11 Dec 2025, 20:50
GNLX GENELUX Corp 12 May 2025 1 -$16,291 4 VP, Clinical Trial Operations 13 May 2025, 17:05
GNLX GENELUX Corp 14 Mar 2025 1 $0 4 VP, Clinical Trial Operations 17 Apr 2025, 16:56
GNLX GENELUX Corp 18 Dec 2024 2 $0 4 VP, Clinical Trial Operations 20 Dec 2024, 20:46
GNLX GENELUX Corp 29 May 2024 2 $0 4 VP, Clinical Trial Operations 07 Jun 2024, 21:40
GNLX GENELUX Corp 19 Feb 2024 3 -$14,520 4 VP, Clinical Trial Operations 08 Jul 2024, 16:30
GNLX GENELUX Corp 15 Dec 2023 2 -$428,180 4 VP, Clinical Trial Operations 18 Dec 2023, 16:15
GNLX GENELUX Corp 07 Dec 2023 1 -$435,995 4 VP, Clinical Trial Operations 08 Dec 2023, 17:57
GNLX GENELUX Corp 21 Nov 2023 1 -$191,555 4 VP, Clinical Trial Operations 22 Nov 2023, 16:15
GNLX GENELUX Corp 17 Nov 2023 2 -$210,431 4 VP, Clinical Trial Operations 21 Nov 2023, 16:15
GNLX GENELUX Corp 24 Oct 2023 3 -$68,151 4 VP, Clinical Trial Operations 25 Oct 2023, 16:15
GNLX GENELUX Corp 10 Oct 2023 4 -$83,262 4 VP, Clinical Trial Operations 11 Oct 2023, 16:10
GNLX GENELUX Corp 26 Sep 2023 5 -$91,328 4 VP, Clinical Trial Operations 27 Sep 2023, 16:10
GNLX GENELUX Corp 20 Sep 2023 3 -$131,786 4 VP, Clinical Trial Operations 21 Sep 2023, 16:35
GNLX GENELUX Corp 15 Sep 2023 4 -$165,230 4 VP, Clinical Trial Operations 18 Sep 2023, 20:13
GNLX GENELUX Corp 13 Sep 2023 1 -$629,927 4 VP, Clinical Trial Operations 15 Sep 2023, 20:06
GNLX GENELUX Corp 11 Sep 2023 1 $0 4 VP, Clinical Trial Operations 12 Sep 2023, 16:24
GNLX GENELUX Corp 30 Aug 2023 1 -$489,060 4 VP, Clinical Trial Operations 30 Aug 2023, 19:22
GNLX GENELUX Corp 18 Aug 2023 1 -$77,478 4 VP, Clinical Trial Operations 22 Aug 2023, 16:14
GNLX GENELUX CORP 17 Feb 2023 1 $0 4 VP, Clinical Trial Operations 02 May 2023, 16:22
GNLX GENELUX CORP 25 Jan 2023 0 $0 3 VP, Clinical Trial Operations 25 Jan 2023, 18:23